TY  - GEN
N2  - Methamphetamine-Associated Heart Failure (MethHF) is a serious complication of methamphetamine use (MU) that is associated with more hospitalizations and greater morbidity and mortality than non-methamphetamine related heart failure (non-MethHF). Currently, regular adherence to guideline-directed medical therapy (GDMT) for heart failure can lead to the reversal of heart failure, even when complete abstinence of methamphetamine is not maintained. However, adhering to GDMT is challenging for patients with MethHF since they experience comorbidities including housing and financial instability, co-occurring mental illness, and reduced social support among others. This quality improvement project utilized the Model for Improvement framework to evaluate patient perceptions of barriers to medication adherence in those with MethHF at a heart failure clinic in the Portland metro area.
AB  - Methamphetamine-Associated Heart Failure (MethHF) is a serious complication of methamphetamine use (MU) that is associated with more hospitalizations and greater morbidity and mortality than non-methamphetamine related heart failure (non-MethHF). Currently, regular adherence to guideline-directed medical therapy (GDMT) for heart failure can lead to the reversal of heart failure, even when complete abstinence of methamphetamine is not maintained. However, adhering to GDMT is challenging for patients with MethHF since they experience comorbidities including housing and financial instability, co-occurring mental illness, and reduced social support among others. This quality improvement project utilized the Model for Improvement framework to evaluate patient perceptions of barriers to medication adherence in those with MethHF at a heart failure clinic in the Portland metro area.
AD  - Oregon Health and Science University
T1  - Methamphetamine-associated heart failure: evaluating patient perceptions of barriers to medication adherence
DA  - 2024-02-28
AU  - Lee, Christine
L1  - https://digitalcollections.ohsu.edu/record/42720/files/Lee.Christine.2024.pdf
PB  - Oregon Health and Science University
LA  - eng
PY  - 2024-02-28
ID  - 42720
L4  - https://digitalcollections.ohsu.edu/record/42720/files/Lee.Christine.2024.pdf
KW  - Heart Failure
KW  - Substance-Related Disorders
KW  - Medication Adherence
KW  - methamphetamine-associated heart failure
KW  - methamphetamine-associated cardiomyopathy
TI  - Methamphetamine-associated heart failure: evaluating patient perceptions of barriers to medication adherence
Y1  - 2024-02-28
L2  - https://digitalcollections.ohsu.edu/record/42720/files/Lee.Christine.2024.pdf
LK  - https://digitalcollections.ohsu.edu/record/42720/files/Lee.Christine.2024.pdf
UR  - https://digitalcollections.ohsu.edu/record/42720/files/Lee.Christine.2024.pdf
ER  -